Malignant Colorectal Neoplasm — Research

Malignant Colorectal Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-13	169,282	`("Malignant Colorectal Neoplasm"[tiab] OR "Colorectal Cancer"[tiab] OR "Malignant Colorectal Tumor"[tiab])`	2026-09-13	pubmed
Last 5 years	2021-01-01 → 2026-12-31	65,243	`("Malignant Colorectal Neoplasm"[tiab] OR "Colorectal Cancer"[tiab] OR "Malignant Colorectal Tumor"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-13	pubmed
Last 12 months	2025-09-13 → 2026-09-13	14,135	`("Malignant Colorectal Neoplasm"[tiab] OR "Colorectal Cancer"[tiab] OR "Malignant Colorectal Tumor"[tiab]) AND (2025/09/13:2026/09/13[dp])`	2026-09-13	pubmed

Data updated 18 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (357)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 251–275 of 357 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review.
· Clin Cancer Res · 2012 · PMID 22357840 · validated civic_curation pubmed
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients.
· BMC Cancer · 2015 · PMID 26508446 · validated civic_curation pubmed
Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival.
· Mol Clin Oncol · 2015 · PMID 26623049 · validated civic_curation pubmed
A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer.